BackIonis Pharmaceuticals Overview
Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Target Price

Analysts' 12-month price predictions for IONS.

Share Price

$50.74

Average Target Price

$58.5015.3% upside

4 analysts in the last 4 months

High: $70 | Low: $44

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-06-27Stifel NicolausPaul Matteis$534.5% upsideOpen
2024-06-17RBC CapitalLuca Issi$7038% upsideOpen
2024-06-14Tudor PickeringWilliam Pickering$4413.3% downsideOpen
2024-05-17BMO CapitalKostas Biliouris$6732% upsideOpen
2023-02-03Leerink Partners$3433% downsideOpen
2022-12-21Morgan Stanley$4021.2% downsideOpen
2022-08-10Citigroup$2844.8% downsideOpen
2022-08-10RBC Capital$6426.1% upsideOpen
2022-06-21Leerink Partners$2746.8% downsideOpen
2022-06-21Piper SandlerDo Kim$558.4% upsideOpen
2022-05-09Morgan Stanley$3040.9% downsideOpen
2022-02-24NeedhamJoseph Stringer$6018.2% upsideOpen
2022-02-24RBC CapitalLuca Issi$6732% upsideOpen
2022-02-01Bank of America SecuritiesJason Gerberry$3040.9% downsideOpen
2021-11-04BarclaysGena Wang$3335% downsideOpen
2021-10-18LaidlawYale Jen$6834% upsideOpen
2021-05-10UBSEsther Rajavelu$37.526.1% downsideOpen
2021-05-05OppenheimerKevin DeGeeter$6324.2% upsideOpen